BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7879258)

  • 1. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
    Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
    Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusions.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1988 Dec; 20(6):1074-8. PubMed ID: 3059589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions.
    Anderson CB; Tyler JD; Rodey GE; Etheredge EE; Anderman CK; Flye MW; Jendrisak MD; Sicard GA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1494-7. PubMed ID: 3547868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
    Anderson CB; Sicard GA; Etheredge EE
    Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
    Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
    Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of donor specific blood transfusion in kidney transplantation.
    Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment of renal allograft recipients with immunosuppression and donor-specific blood.
    Anderson CB; Tyler JD; Sicard GA; Anderman CK; Rodey GE; Etheredge EE
    Transplantation; 1984 Dec; 38(6):664-8. PubMed ID: 6239414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
    Haisa M; Sakagami K; Matsumoto T; Kawamura T; Uchida S; Fujiwara T; Shiozaki S; Inagaki M; Orita K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
    Leivestad T; Albrechtsen D; Flatmark A; Thorsby E
    Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific transfusion.
    Iwaki Y; Terasaki PI
    Clin Transpl; 1986; ():267-75. PubMed ID: 3154415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of donor-specific transfusions on renal transplantation in children.
    Potter D; Garovoy M; Hopper S; Terasaki P; Salvatierra O
    Pediatrics; 1985 Sep; 76(3):402-5. PubMed ID: 3162150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
    Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era.
    Marti HP; Henschkowski J; Laux G; Vogt B; Seiler C; Opelz G; Frey FJ
    Transpl Int; 2006 Jan; 19(1):19-26. PubMed ID: 16359373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors on graft survival of living donor kidney transplantation.
    Park YH; Min SK; Lee JN; Lee HH; Jung WK; Lee JS; Lee JH; Lee YD
    Transplant Proc; 2004 Sep; 36(7):2023-5. PubMed ID: 15518732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.